University of PennsylvaniaPhiladelphia, PA
Disclosures:
188 - Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer
Monday, September 30, 202410:45 AM – 10:55 AM ET